Antibodies, the molecular workhorses of protein research, have traditionally been one of the most difficult reagents to procure. Using innovative new technologies, though, a burgeoning antibody production industry is turning these molecules into commodities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
25 November 2009
NOTE: In the version of this article initially published, the images used in the first two illustrations were incorrectly attributed to T. Gerngross instead of Adimab. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dove, A. Antibody production branches out. Nat Methods 6, 851–856 (2009). https://doi.org/10.1038/nmeth1109-851
Issue date:
DOI: https://doi.org/10.1038/nmeth1109-851
